Grace Therapeutics, Inc. (GRCE) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

-$7.8M

Total Assets (FY2025)

$66.7M

Total Equity (FY2025)

$63.9M

Cash Flows from Operating Activities (FY2025)

-$8.9M

Source: Grace Therapeutics, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.